Ebetrexat 20 mg/ml otopina za injekciju u napunjenoj štrcaljki
| Name | Ebetrexat 20 mg/ml otopina za injekciju u napunjenoj štrcaljki |
|---|---|
| Marketing Authorisation Number | HR-H-123483008 |
| Active Substance | dinatrijev metotreksat |
| Composition | 1 ml otopine za injekciju sadrži 20 mg metotreksata u obliku dinatrijevog metotreksata |
| Pharmaceutical Form | otopina za injekciju u napunjenoj štrcaljki |
| Manufacturer | Ebewe Pharma GmbH Nfg. KG, Unterach am Attersee, Austrija Fareva Unterach GmbH, Unterach, Austrija |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 05.02.2018 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/16-02/324 |
| Registration Number | 381-12-01/30-18-08 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | L01BA01 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Educational materials for patients / caregivers |
Vodič za bolesnike i njegovatelje, verzija 1, ožujak 2018 |
Packaging
Direct Healthcare Professional Communication
| Name | Date | Download |
|---|---|---|
| Pismo zdravstvenim radnicima o preporukama za sprječavanje potencijalno fatalnih pogrešaka u doziranju metotreksata za liječenje upalnih bolesti | 02.12.2019 | Sandoz d.o.o., Pliva Hrvatska d.o.o., Actavis Group PTC ehf, Cipla Europe NV |